The specific immune response couples recognition of foreign antigens with a variety of effector mechanisms that are broadly classified as either humoral or cell mediated . Humoral immune responses are mediated by antibody produced by activated B cells while cell-mediated responses involve macrophage and cytolytic T cell activation. Both forms of immunity require participation of activated CD4' T cells. Recent studies have shown that cloned lines of CD4* T cells able to elicit effector responses characteristic of humoral or cell mediated immunity are of distinct subsets (1-3), producing different cytokines (4) that are believed to account for these activities. To examine whether the mechanism that determines the effector class of a given immune response involves normal correlates of cloned CD4' subsets in vivo, we have studied an immune response in which the effector phenotype is controlled by a MHC class II gene. We show that different cytokines are produced by CD4' T cells responding to the same antigen in mice of different MHC genotypes. Moreover, the CD4' T cells responding in mice of different MHC genotypes also differ in their ability to induce antibody production . These data demonstrate that MHC class II genotype can control the -functional outcome of an immune response.
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Materials and Methods
Brie,f Definitive Report Mice. A.SW/Snj and A.BY/Snj mice (female 6-8 wk old) were purchased from TheJackson Laboratory, Bar Harbor, ME.
Antigens. Type IV human collagen (collagen IV) was purified and characterized as previously described (5) .
Lymph Node CD4' T Cell Proliferation Assay. Lymph node cells were isolated from congenic mice immunized 10 d previously with 50 jug of collagen IV in CFA (H37Ra ; Difco Laboratories, Detroit, MI) at the base of the tail (5) . CD4' T cells were prepared as described (6) . CD4' T cells were cultured for 96 h at 4 x 105 cells/well with 105 irradiated (3,000 rad) syngeneic T-depleted splenic APC/well as described previously (5) .
Hapten-specific IgG Antibody Responses. 2 x 10 5 CD4' T cells were mixed with 106 syngeneic T cell-depleted spleen cell from TNP-OVA-primed mice and varying concentrations of TNRcollagen IV (only the optimal concentration of 0 .05 jig/ml is shown) in the presence or absence of 1 Pg/ml purified (rat IgGl) mAb, 111111, or mAb35 (isotype-matched control antibody) . Serial dilutions of 6 d supernatants were incubated on TNP-BSA coated plates, followed by the addition of biotinylated andisotype reagents, avidin-peroxidase, and finally BRIEF DEFINITIVE REPORT substrate buffer. Monoclonal antiTNP isotype controls were used to establish the specificity of the ELISA.
Analysis of Lymph Node CD4' T Cell Blastsfor IL4, IL2, and IFN-y mRNA by In Situ Hybridization. Mice were immunized as above and lymph node cells cultured with 25 ,ug/ml collagen IV as described for Fig. 1 . After 48 h cells were fractionated into CD4' T cells as above and blast CD4' T cells were obtained from the interface of 50-607o Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden) by centrifugation . The procedure used for in situ hybridization has been described previously (6) ; >400 cells contained in >5 fields ofview were counted for each slide under x 1,000 magnification . Background hybridization was determined with sense-strand probes .
Results and Discussion Both humoral and cell-mediated protective immune responses are driven by activated CD4+ T cells. While cloned T cell lines differ in their functional capabilities, it is of interest to determine if similar functional specialization exists in normal CD4 + T cells . Previous studies of this question have examined susceptibility and resistance of mice to chronic infection with Letshmania major (7, 8) ; antibodies to cell surface molecules (9, 10) ; lectin binding (11); or cytokines produced by single CD4 + T cells (6) . While these studies suggest that subsets of CD4 + T cells similar to those derived by cloned lines exist in vivo, no understanding of the mechanism of selecting distinct functional effects or subsets has been obtained . In this report, we examine the CD4' T cell cytokine production and helper activity during a response to type IV human collagen (collagen IV), where it has been observed that mice expressing the MHC class II gene product I-AS display strong lymph node antigen-specific T cell proliferation in the absence of significant antibody production, while all other genotypes tested lacked proliferative responses but produced abundant antigen-specific antibody (5) . Previous studies of the immune response to collagen IV did not examine purified CD4' T cells, leaving open the possibility that the differences observed reflected inhibition of responses by other cell types . We therefore examined the responses of purified CD4' T cells from mice of different MHC genotypes for the ability to proliferate in response to collagen IV ( Fig. 1 ) and to help B cells produce antiTNP antibody in response to TNP-collagen-IV (Fig. 2 a) . As shown, CD4' T cells from mice expressing I-A$ (here, A.SW) proliferate in response to low doses of collagen IV, while CD4' T cells from mice expressing I-Ab (here, the congenic strain A.BY) do not respond even to high doses of collagen IV. This difference is antigen specific, since CD4' T cells from both 200 FIGURE 1. Lymph node CD4' T cell proliferative response to human col-, lagen IV CD4' T cells from I-Aaand I-Ab-primed congenic strains were analyzed for recall proliferation to either collagen IV or 5 wg/ml KLH in vitro. Error bars represent the SD of triplicate wells; background proliferation (no antigen) was <5,000 cpm and is subtracted from these values. Representative data are shown . In separate experiments, I-A' proliferative 1 10 100 KLH responses to collagen IV were consis-TNP-COLLAGEN IV (II GIYL) tently 3 a log higher than I-Ab. (Fig.  2 a) . This difference in the secretion of IgG1 antiTNP antibody was observed at all TNP-collagen concentrations tested (data not shown) . Since the secretion ofIgG1 has been shown to be influenced by IL-4 (12, 13), it was important to determine if the IgG1 response to TNRcollagen IV required IL-4 production by T cells from I-Ab mice . As is shown in Fig. 2 b, the mAb 111311, which is specific for murine IL-4, significantly and specifically blocks the synthesis ofIgGI antiTNP in this system . Thus, IL-4 production appears to be coupled to IgG1 antibody production in this system . To further examine whether the dichotomy in responses to collagen IV seen between I-A-and I-Ab mice reflected selective activation of Th-l-like or Th2-like CD4' T cells, respectively, CD4' T cells from immunized mice were restimulated with collagen IV in vitro, and the responding T cell blasts were assayed for IL-4, IL-2, and IFN-y expression by in situ hybridization. These cytokines are selectively expressed by Th2 (IL-4 producing) and Thl (IL-2/IFN-y producing) subsets of CD4' T cell clones (4). It can be seen (Fig. 3) that the proliferative response to collagen IV in I-A' mice is accompanied by the expression of IFN-y (Fig. 3 b) and IL-2 ( Fig.  3 a) mRNA, but not expression of IL-4 ( Fig . 3 c) mRNA (background hybridization was negligible ; data not shown) . By contrast, the response to collagen IV by T cells from I-Ab mice is accompanied by the expression of IL-4 mRNA but not IFN-y mRNA. These results have been confirmed by bioassays ofsupernatants from these and replicate cell cultures using cytokine-responsive T cell lines and specific mAbs to measure individual cytokines. We have consistently observed IFN-y only in I-AS cell culture supernatants, IL-2 at low levels in I-A' and high levels in I-A' supernatants, and IL-4 when detected only in I-A' culture supernatants (data not shown) . Thus, the induced cytokine response of normal CD4`T cells to this antigen is determined by the MHC genotype of the mouse. The present experiments confirm earlier studies in other experimental systems that functionally distinct sets of CD4+ T cells arise selectively in an in vivo immune response (7, 8, 14) . The selective activation ofIL-4-producing cells in strains ofmice that also produce antibody to collagen IV, and the fact that IL-4 production was not detected in strains of mice that do not produce specific antibody, support our previous observations with Th2 cloned lines (1) suggesting that IL-4 production correlates with helper function in specific antibody responses.
Whether a subdivision of CD4+ T cells into Thl and Th2 cells occurs before or as a result of antigenic stimulation is not yet clear. It has recently been suggested that IL-4-producing cells are a consequence of memory responses, i.e., secondary stimulation, whereas IL-2 producers dominate primary immune responses (9, 15, 16) . The present results argue against a simple sequential mechanism, as we observed strong antigen-specific recall T cell proliferative responses that were dominated by IL-2/IFN-y-producing CD4+ T cells. Rather, the differential activation ofantigen-specific Thl-like and Th2-like cells in mice of distinct class II MHC genotype strongly suggests that events involved in antigen presentation per se contribute to the selective activation of a particular subset of T cell .
There are three possible mechanisms by which class II MHC genotype might control the subset of CD4+ T cells activated during a specific immune response, Lymphokine mRNA expression by collagen IV-primed CD4`T cells . Steady-state mRNA of IL-2 (a), IFN--y (b), and IL-4 (c) was measured by in situ hybridization with ribo probes prepared from lymphokine-specific cDNA . Blast cells were obtained as described in Materials and Methods from collagen IV-primed I-A' and I-Ab congenic mice and compared for lymphokine mRNA . The frequencies of positive cells recovered from the total lymph node cell populations were similar, i.e ., 1 .7% (A.BY) and 1 .6% (ASW), and indicate frequencies similar to those reported for antigen-stimulated IL-2-and IL-4-producing T cells as analyzed by limiting dilution analysis (16) . and each applies equally to any of several models of CD4' subset differentiation. Ifthe effects observed reflect the binding ofdifferent peptides by different I-A alleles, then this implies that T cells of different functional capabilities also differ in their TCR repertoire . This conclusion is incompatible with optimal functioning of immune surveillance, since there is no a priori mechanism for determining if a particular epitope will be expressed on an intracellular or extracellular bacterium. However, in single cases like collagen IV, this mechanism could operate. In conclusion, our studies demonstrate that class II MHC genotype can control whether T cells responding to a given antigen make IL-2 and IFN-y, or IL-4. There are several mechanisms that can explain this result . The critical issue now is to determine which of them is/are correct, and then to determine at what stage in CD4' T cell development this functional specialization occurs.
Summary
The present results demonstrate that CD4' T cells activated in the primary in vivo response to antigen produce distinct patterns of cytokines depending upon the MHCclass II haplotype of the responding mice. I-As mice were found to selectively activate IL-2/IFN-y-producing CD4' T cells, whereas I-Ab mice exhibited selective activation of IL-4-producing CD4' T cells in response to collagen IV. The effector response phenotype was found to correlate with the cytokine phenotype of CD4' T cells activated in vivo; IL-2/17N-y-producing cells giving rise to proliferative (cell-mediated) responses, IL-4-producing cells leading to secondary IgG (humoral) responses. Together the data support the notion that the outcome of a given immune response (e.g., protection vs. onset, tolerance vs. autoimmunity) may be determined in part by the type of CD4`T cells initially activated by antigen. Moreover, the present experiments demonstrate for the first time that polymorphism
